Stock HRTX HERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Heron Therapeutics, Inc.

Equities

HRTX

US4277461020

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
2.71 USD -2.17% Intraday chart for Heron Therapeutics, Inc. -7.82% +59.41%
Mar. 21 Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 CI
Mar. 13 Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup DJ

Evolution of the average Target Price on Heron Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7105ab7213847269be9cc1.FeaE7yXSzu8p2iSBYSCeDDOwUy--qJmDSQmDqsIsTWw.ZIPimmCo-ddxhUXIU3jSSFnmJUPW26GuIjHQkvRuOxRKpLXbVbORqWG2cQ~41f150a5625c57549c88d1a553fbcd37

Analyst Recommendations on Heron Therapeutics, Inc.

Needham Adjusts Price Target on Heron Therapeutics to $5 From $4, Keeps Buy Rating MT
Needham Trims Price Target on Heron Therapeutics to $4 From $5, Keeps Buy Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $5 From $6, Maintains Buy Rating MT
Needham Adjusts Heron Therapeutics' Price Target to $6 From $7, Keeps Buy Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $6 From $7, Maintains Buy Rating MT
Evercore ISI Adjusts Price Target on Heron Therapeutics to $10 From $15, Maintains Outperform Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $7 From $8, Keeps Buy Rating MT
Needham Trims Price Target on Heron Therapeutics to $8 From $10, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target for Heron Therapeutics to $12 From $20, Maintains Overweight Rating MT
Needham Adjusts Heron Therapeutics' Price Target to $14 from $16, Keeps Buy Rating MT
Cowen & Co Adjusts Heron Therapeutics Price Target to $13 From $31, Maintains Outperform Rating MT
Needham & Co Adjusts Heron Therapeutics Price Target to $16 From $24, Maintains Buy Rating MT
HERON THERAPEUTICS : Stifel Adjusts Heron Therapeutics' Price Target to $25 from $20, Keeps Buy Rating MT
HERON THERAPEUTICS : SVB Leerink Adjusts Heron Therapeutics' Price Target to $24 From $21, Keeps at Outperform MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.71 USD
Average target price
7 USD
Spread / Average Target
+158.30%
High Price Target
9 USD
Spread / Highest target
+232.10%
Low Price Target
5 USD
Spread / Lowest Target
+84.50%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Heron Therapeutics, Inc.

Needham & Co.
Evercore ISI
Cantor Fitzgerald
Cowen

Ratings for Heron Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. Consensus Heron Therapeutics, Inc.